UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044878 |
|---|---|
| Receipt number | R000050277 |
| Scientific Title | Clarification of the gut microbiome in esophageal cancer patients which is closely influenced by lifestyle |
| Date of disclosure of the study information | 2021/07/19 |
| Last modified on | 2021/07/16 07:52:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clarification of the gut microbiome in esophageal cancer patients which is closely influenced by lifestyle
Acronym
Clarification of the gut microbiome in esophageal cancer patients.
Scientific Title
Clarification of the gut microbiome in esophageal cancer patients which is closely influenced by lifestyle
Scientific Title:Acronym
Clarification of the gut microbiome in esophageal cancer patients.
Region
| Japan |
Condition
Condition
esophageal squamous cell carcinoma
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify the dysbiosis in esophageal cancer patients which is closely influenced by lifestyle
Basic objectives2
Others
Basic objectives -Others
To clarify the effects of neoadjuvant treatment and surgery on the gut microbiome in esophageal cancer patients
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Characteristics of the gut microbiome in esophageal cancer patients.
Effect of chemoradiation therapy and surgery on gut microbiota in esophageal cancer patients.
Key secondary outcomes
Association with gut microbiome and surgical outcome, prognosis, clinical outcomes, blood test data, and gastrointestinal symptoms
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1)Patients who are diagnosed with esophageal squamous cell carcinoma diagnosed at Kyushu University Hospital.
(2)Patients who underwent neoadjuvant treatment and surgery.
Key exclusion criteria
Patients who were unsuitable for the study
Target sample size
21
Research contact person
Name of lead principal investigator
| 1st name | Eiji |
| Middle name | |
| Last name | Oki |
Organization
Graduate School of Medical Sciences, Kyushu University
Division name
Department of Surgery and Science
Zip code
812-8582
Address
3-1-1, Maidashi, Higashiku, Fukuoka city, Fukuoka, Japan
TEL
092-642-5466
okieiji@surg2.med.kyushu-u.ac.jp
Public contact
Name of contact person
| 1st name | Hirofumi |
| Middle name | |
| Last name | Hasuda |
Organization
Graduate School of Medical Sciences, Kyushu University
Division name
Department of Surgery and Science
Zip code
812-8582
Address
3-1-1, Maidashi, Higashiku, Fukuoka city, Fukuoka, Japan
TEL
092-642-5466
Homepage URL
h-hasuda@surg2.med.kyushu-u.ac.jp
Sponsor or person
Institute
Kyushu University
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Fukuoka Dental College Hospital
Biofermin Pharmaceutical Co., Ltd.
Name of secondary funder(s)
IRB Contact (For public release)
Organization
KYUSHU UNIVERSITY Center for Clinical and Translational Research(CCTR)
Address
3-1-1 Maidashi, Higashi-ku
Tel
092-642-5774
byskenkyu@jimu.kyushu-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 07 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
21
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2021 | Year | 03 | Month | 31 | Day |
Date of IRB
| 2021 | Year | 03 | Month | 31 | Day |
Anticipated trial start date
| 2021 | Year | 03 | Month | 31 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
[Study design]
observational study
[Patients]
Esophageal cancer patients who have been treated at Kyushu University Hospital.
Patients who meet the inclusion criteria
Patients with consent
[measurement item]
Gut microbiome
Management information
Registered date
| 2021 | Year | 07 | Month | 16 | Day |
Last modified on
| 2021 | Year | 07 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050277
